Jump Financial, LLC Seagen Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $469,127 - $556,262	3,997 Added 7.63%	56,400 $7.25 Million
Q3 2022 Nov 07, 2022	BUY	$135.27 - $180.11 $6.1 Million - $8.12 Million	45,087 Added 616.28%	52,403 $7.17 Million
Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $796,053 - $1.31 Million	7,316 New	7,316 $1.29 Million
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $191,615 - $252,875	-1,602 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $228,397 - $305,757	1,602 New	1,602 $248,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.